ADMA Biologics Inc (ADMA) ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

ADMA Biologics Inc (NASDAQ: ADMA) FY 2026 Other Release

Newsdesk: